Your browser doesn't support javascript.
loading
Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists.
Bonde, Tiago M; Garmo, Hans; Stattin, Pär; Nilsson, Per; Gunnlaugsson, Adalsteinn; Swanberg, Daniela; Robinson, David.
Affiliation
  • Bonde TM; Department of Urology, Ryhov Hospital, Jönköping, Sweden.
  • Garmo H; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Stattin P; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Nilsson P; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Sweden.
  • Gunnlaugsson A; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund University, Sweden.
  • Swanberg D; Department of Surgery, Höglandssjukhuset, Eksjö, Sweden.
  • Robinson D; Department of Urology, Höglandssjukhuset, Eksjö, Sweden.
Acta Oncol ; 62(12): 1815-1821, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37850633
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Brachytherapy Limits: Humans / Male Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Sweden
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Brachytherapy Limits: Humans / Male Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Sweden